|
|
Intermittent Antiretroviral Therapy Does Not Improve Quality of Life
|
| Link ID |
4137 |
| Title |
Intermittent Antiretroviral Therapy Does Not Improve Quality of Life |
| Url |
http://www.medscape.com/viewarticle/571627?src=rss |
| Description |
Quality of life declines in HIV-infected patients on CD4-guided intermittent antiretroviral therapy (ART) compared with those who continue on ART without interruptions, according to a substudy of the Strategies of Management of Antiretroviral Therapy (SMART), which was halted in January 2006 after it became clear that patients in the intermittent arm had higher mortality and morbidity rates. Reuters Health Information |
| Category |
Articles > HIV/AIDS |
| Keywords |
|
| Date |
Mar 20, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > HIV/AIDS |
| 1. |
HIV Prevalence Estimates -- United States, 2006
|
|
|
With 80% of states reporting name-based HIV diagnoses as of 01/2006, an extended back-calculation method is now used to estimate HIV prevalence more accurately. What are the HIV prevalence estimates?
Morbidity & Mortality Weekly Report
|
| 2. |
DTaP Booster Raises Waning Antibody Levels in Children on HAART
|
|
|
Booster doses of the diphtheria-tetanus-acellular pertussis (DTaP) vaccine help to keep protective antibody levels up in HIV-infected children on highly active antiretroviral therapy (HAART) without significant adverse effects, investigators report. Reuters Health Information
|
| 5. |
Liposomal Doxorubicin Plus IL-12 Effective in AIDS-Related Kaposi Sarcoma
|
|
|
Thirty of 36 patients with advanced AIDS-related Kaposi sarcoma treated with cyclical pegylated liposomal doxorubicin plus interleukin-12 (IL-12) had a major response to treatment, according to investigators at the National Cancer Institute in Bethesda, Maryland. Reuters Health Information
|
|
|
